We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

Back to rankings

265 hedge funds and large institutions have $997M invested in Avanos Medical in 2023 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 78 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more call options, than puts

Call options by funds: $541K | Put options by funds: $118K

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

13% more capital invested

Capital invested by funds: $884M → $997M (+$113M)

2.49% more ownership

Funds ownership: 93.14% → 95.63% (+2.5%)

2% more funds holding

Funds holding: 260 → 265 (+5)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 78

Holders
265
Holders Change
+5
Holders Change %
+1.92%
% of All Funds
3.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
41
Increased
67
Reduced
78
Closed
35
Calls
$541K
Puts
$118K
Net Calls
+$423K
Net Calls Change
+$438K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$10.1M
2
BlackRock
BlackRock
New York
+$6.77M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
+$4.72M
4
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$4.66M
5
RC
RGM Capital
Florida
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
PIM
Paradice Investment Management
Colorado
-$12.8M
2
HA
Heartland Advisors
Wisconsin
-$3.76M
3
Invesco
Invesco
Georgia
-$2.54M
4
ECM
ExodusPoint Capital Management
New York
-$1.9M
5
Two Sigma Investments
Two Sigma Investments
New York
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allspring Global Investments
276
Allspring Global Investments
North Carolina
– -$53.3K -2,636 Closed
HT
277
Headlands Technologies
Illinois
– -$13.9K -687 Closed
PPC
278
Park Place Capital
Alabama
– -$9.52K -471 Closed
SCA
279
Stonebridge Capital Advisors
Minnesota
– -$8.84K -437 Closed
Creative Planning
280
Creative Planning
Kansas
– -$5.08K -251 Closed
EARNEST Partners
281
EARNEST Partners
Georgia
– -$4.25K -210 Closed
GA
282
GoalVest Advisory
New York
– -$3.58K -177 Closed
LC
283
Lindbrook Capital
California
– -$1.88K -93 Closed
CSPIA
284
Cary Street Partners Investment Advisory
Virginia
– -$1.74K -86 Closed
FRA
285
Front Row Advisors
California
– -$1.21K -60 Closed
HPC
286
HM Payson & Co
Maine
– -$971 -48 Closed
CB
287
Community Bank
New York
– -$505 -25 Closed
FAM
288
Flaharty Asset Management
Florida
– -$485 -24 Closed
VWM
289
Valley Wealth Managers
New Jersey
– -$425 -21 Closed
PCFFS
290
Pacific Center for Financial Services
California
– -$304 -15 Closed
M
291
MOTCO
Texas
– -$263 -13 Closed
JWA
292
JFS Wealth Advisors
Pennsylvania
– -$223 -11 Closed
GWSG
293
GPS Wealth Strategies Group
Colorado
– -$162 -8 Closed
WWP
294
WR Wealth Planners
Missouri
– -$162 -8 Closed
SIC
295
SJS Investment Consulting
Ohio
– -$142 -7 Closed
TWP
296
TFO Wealth Partners
Ohio
– -$153 -6 Closed
8 9 10 11
12

AVNS Hedge Fund Activity: Q4 2023 in Review

265 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2023, worth a combined $997M — up 13% from $884M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new AVNS positions and 35 closed out — a net gain of 6 holders — while 67 added to existing stakes and 78 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $10.1M. The largest seller was Paradice Investment Management, cutting an estimated $12.8M.

  • 265 institutional investors held Avanos Medical (AVNS) as of Q4 2023, up from 260 in Q3 2023.
  • Funds reported $997M of Avanos Medical stock for Q4 2023, up 13% quarter-over-quarter.
  • 41 funds opened new Avanos Medical positions in Q4 2023 and 35 closed out, a net change of +6 holders.
  • The largest Avanos Medical buyer in Q4 2023 was Morgan Stanley, an estimated $10.1M added.
  • The largest Avanos Medical seller in Q4 2023 was Paradice Investment Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2023.